ArticleScientific reports2025
CLCF1 is associated with perineurial invasion and prognosis in colorectal cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perineural invasion (PNI) is implicated in tumor invasion, metastasis, cancer-related pain, and adverse clinical outcomes across various malignancies. Nonetheless, the core genes and molecular mechanisms underlying PNI in colorectal cancer (CRC) remain inadequately understood. The objective of our study was to identify key genes associated with PNI in CRC through bioinformatic analysis. Transcriptomic and clinical data for CRC were obtained from the Cancer Genome Atlas (TCGA) dataset. Using the limma package, we identified 2,446 differentially expressed genes (DEGs) between CRC samples with and without PNI. Additionally, 1,793 immune-related genes (IRGs) were obtained from the ImmPort database. The intersection of differentially expressed immune-related genes (DEIRGs) was subsequently employed for functional enrichment analysis and the development of risk models. A novel prognostic model related to PNI was successfully developed and validated, demonstrating its independent prognostic value in CRC. Cardiotrophin-like cytokine factor 1 (CLCF1) was identified as a key prognostic marker associated with PNI in CRC, with elevated expression observed in tumor samples. CLCF1 was shown to enhance the proliferation, invasion, and migration capabilities of CRC cells, suggesting its potential as a therapeutic target for CRC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.